Literature DB >> 3497093

Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation.

K Guy, P G Middleton, C M Steel.   

Abstract

Variant sublines of the Burkitt's lymphoma cell line Namalwa, previously shown to differ in MHC class II antigen and immunoglobulin expression, have been tested with monoclonal antibodies defining B-cell specific clusters of differentiation (CD). The Namalwa sublines express antigens recognized by the CD antibodies in patterns that indicate that the cells are arrested at different stages of differentiation.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3497093      PMCID： PMC1453395     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  14 in total

1.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes.

Authors:  T F Tedder; A Forsgren; A W Boyd; L M Nadler; S F Schlossman
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

3.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

4.  Signal sequences distinguish class II histocompatibility antigen beta chains of different loci.

Authors:  K Gustafsson; K Wiman; D Larhammar; L Rask; P A Peterson
Journal:  Scand J Immunol       Date:  1984-01       Impact factor: 3.487

Review 5.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.

Authors:  C Navarrete; N Fernandez; M C Alonso; H Festenstein
Journal:  Hum Immunol       Date:  1986-05       Impact factor: 2.850

7.  Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.

Authors:  P Hokland; J Ritz; S F Schlossman; L M Nadler
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

8.  Mapping by gene dosage, using aneuploid human lymphoid cell lines.

Authors:  M Soos; M Shade; H Bell; M Moxley; C M Steel
Journal:  Ann Hum Genet       Date:  1981-05       Impact factor: 1.670

9.  Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

Authors:  S J Korsmeyer; P A Hieter; J V Ravetch; D G Poplack; T A Waldmann; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Early events in Epstein-Barr virus infection provide a model for B cell activation.

Authors:  D A Thorley-Lawson; K P Mann
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307
View more
  1 in total

1.  A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Authors:  Floriane Fusil; Sara Calattini; Fouzia Amirache; Jimmy Mancip; Caroline Costa; Justin B Robbins; Florian Douam; Dimitri Lavillette; Mansun Law; Thierry Defrance; Els Verhoeyen; François-Loïc Cosset
Journal:  Mol Ther       Date:  2015-08-18       Impact factor: 11.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.